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Abstract
Background: Genomic imprinting is an important epigenetic process involved in regulating placental and foetal
growth. Imprinted genes are typically associated with differentially methylated regions (DMRs) whereby one of the
two alleles is DNA methylated depending on the parent of origin. Identifying imprinted DMRs in humans is
complicated by species- and tissue-specific differences in imprinting status and the presence of multiple regulatory
regions associated with a particular gene, only some of which may be imprinted. In this study, we have taken
advantage of the unbalanced parental genomic constitutions in triploidies to further characterize human DMRs
associated with known imprinted genes and identify novel imprinted DMRs.
Results: By comparing the promoter methylation status of over 14,000 genes in human placentas from ten
diandries (extra paternal haploid set) and ten digynies (extra maternal haploid set) and using 6 complete
hydatidiform moles (paternal origin) and ten chromosomally normal placentas for comparison, we identified 62
genes with apparently imprinted DMRs (false discovery rate <0.1%). Of these 62 genes, 11 have been reported
previously as DMRs that act as imprinting control regions, and the observed parental methylation patterns were
concordant with those previously reported. We demonstrated that novel imprinted genes, such as FAM50B, as well
as novel imprinted DMRs associated with known imprinted genes (for example, CDKN1C and RASGRF1) can be
identified by using this approach. Furthermore, we have demonstrated how comparison of DNA methylation for
known imprinted genes (for example, GNAS and CDKN1C) between placentas of different gestations and other
somatic tissues (brain, kidney, muscle and blood) provides a detailed analysis of specific CpG sites associated with
tissue-specific imprinting and gestational age-specific methylation.
Conclusions: DNA methylation profiling of triploidies in different tissues and developmental ages can be a
powerful and effective way to map and characterize imprinted regions in the genome.
Background
Genomic imprinting is a phenomenon in which one of
the two alleles of a gene is expressed in a parent-of-ori-
gin manner [1]. Imprinted genes are thought to be parti-
cularly important to placental and foetal growth and
development and may help regulate growth in response
to maternal and foetal signals in utero [2]. To date,
around 60 imprinted genes have been identified in
humans (http://www.geneimprint.com), largely after first
being identified in mice or through characterization of
specific imprinting disorders such as Prader-Willi syn-
drome and Angelman syndrome or Beckwith-Wiede-
mann syndrome. However, many genes are imprinted in
mice but are not known to be in humans, for example,
Impact [3]. Furthermore, many genes are imprinted only
in specific tissues, for example, Ube3a, which is mater-
nally expressed in the brain but biparentally expressed
in other tissues [4], or may be polymorphically
imprinted, for example, IGF2R [5]. These issues compli-
cate the discovery and characterization of imprinted
genes in humans.
The importance of imprinted genes for placental and
foetal development was initially demonstrated in mice
by observations that parthenogenetic embryos (maternal
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origin, digynic diploid) could show embryonic differen-
tiation but failed to form extraembryonic components
[6]. In contrast, androgenetic embryos (paternal origin,
diandric diploid) had poorly developed embryos, but the
trophoblasts showed extensive proliferation [7]. The par-
allel observations in humans are ovarian teratomas
(parthenogenetic), which are a rare form of tumour that
consists of a variety of embryonic tissues or organs but
no placental tissues, and complete hydatidiform moles
(CHMs) (androgenetic), which consist of abnormal pla-
cental growth characterized by trophoblast hyperplasia
but no (or rare) embryonic structures. The parental con-
flict theory developed to explain the evolution of
imprinted genes [8] suggests that paternally expressed
genes tend to promote growth of the offspring at the
expense of the mother, while maternally expressed
genes act as growth-limiting factors to conserve mater-
nal resources [8].
Most imprinted genes possess differentially methylated
regions (DMRs) whereby allelic methylation depends on
the parent of origin [1]. DMRs established through the
germline are called ‘gametic’ or ‘primary’ DMRs. These
often coincide with imprinting control regions (ICRs),
which regulate gene expression and further epigenetic
modifications [9-11]. Their methylation status is thought
to be maintained in all somatic lineages once acquired.
Other DMRs, called ‘somatic’ or ‘secondary’ DMRs, are
established after fertilization and may be tissue-specific
[10,11].
Since most imprinted genes contain DMRs, comparing
DNA methylation profiles between tissues with unba-
lanced parental constitutions provides an approach to
identify and characterize imprinted genes in the gen-
ome. One approach is to compare the DNA methylation
profile of paternally derived CHMs to that of maternally
derived ovarian teratomas [12]. Indeed, several novel
imprinted genes have been identified previously by using
this strategy [13,14]. However, such comparisons are
limited by the fact that the tissues present in ovarian
teratomas and CHMs are highly abnormal and are not
of comparable origin, with teratomas being embryonic
and CHMs being strictly placental. Many differences
may reflect tissue-specific methylated genes, since tis-
sue-specific DMRs are numerous and are established in
early pregnancy [15]. CHMs also present with highly
proliferative trophoblasts that can lead to increased risk
of choriocarcinoma, and hypermethylation of nonim-
printed genes has been reported in CHMs [16].
In humans, triploidy (the presence of three complete
haploid genomes) occurs spontaneously in 2% to 3% of
pregnancies, and, while such pregnancies frequently end
in miscarriage, they can survive into the foetal period
and, very rarely, to term [17]. We propose that a com-
parison between diandric and digynic triploidies, in
which development is much less severely altered than in
CHMs and teratomas, provides a powerful approach for
the identification and characterization of imprinted
genes in the human genome. The diandric triploid phe-
notype (two paternal plus one maternal haploid gen-
omes) is characterized by a normal-sized or only
moderately growth-restricted foetus with a large and
cystic placenta with trophoblast hyperplasia, while the
digynic triploid phenotype (two maternal plus one pater-
nal haploid genomes) is characterized by an intrauterine
growth-restricted foetus and a very small placenta with
no trophoblast hyperplasia [17]. Importantly, embryo
and foetal development are largely similar between dia-
ndric and digynic triploidy, with growth differences
likely arising largely as a consequence of differences in
placental function [18]. Furthermore, while small, digy-
nic placentas have a grossly normal structure. Diandric
placentas show features similar to a CHM, but their
development is much less severely altered than in a
CHM, and the placenta can support growth of a foetus
at least to some degree.
Although it was previously suggested that DNA
methylation may be less important in regulating
imprinting in placental tissue as compared to foetal tis-
sue, we recently demonstrated that the DNA methyla-
tion status of many known imprinted DMRs is strictly
maintained in triploid placentas and can be used to dis-
tinguish diandric from digynic triploidy [19]. Therefore,
in the present study, we compared the DNA methyla-
tion profiles of placentas from diandric and digynic tri-
ploidies using the Infinium HumanMethylation27
BeadChip array (Illumina, Inc., San Diego, CA, USA),
which targets over 27,000 CpG loci within the proximal
promoter regions of approximately 14,000 genes [20].
Methylation levels in chromosomally normal placentas,
CHMs and maternal blood samples were used as refer-
ence points for comparison. Using this strategy, we
identified the majority of known imprinted ICRs on the
array and many novel imprinted DMRs in the genome.
For a subset of genes, we identified expressed poly-
morphisms and informative mother-placenta pairs,
which were used to demonstrate parent-of-origin biases
in allelic expression. We also demonstrated that com-
plex DNA methylation domains that regulate imprinted
genes can be mapped by comparing the methylation
patterns in different tissues and different gestational
ages of placentas.
Results
DNA methylation profile analysis in placenta and blood
samples
To generate DNA methylation profiles from triploidies, we
assayed placental DNA from ten diandric and ten digynic
triploidies on the Illumina Infinium HumanMethylation27
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BeadChip panel. In addition, ten chromosomally normal
placentas, 6 CHMs (diandric diploid, no maternal contri-
bution) and ten maternal whole-blood samples were
included for comparison. After background adjustment
and normalization, we performed unsupervised hierarchi-
cal clustering with all the samples based on a distance
measure of 1-r, where r is the Pearson correlation coeffi-
cient between different samples. This revealed three dis-
tinct groups of clusters: CHMs, triploid and normal
placentas, and blood (Figure 1). The blood cluster is more
distant from the two other clusters of placentas, confirm-
ing that there are many DNA methylation differences
between blood and placenta [21-23]. Although CHMs are
trophoblast-derived, they show a distinct methylation pro-
file from the triploid and normal placentas, which prob-
ably reflects not only the lack of a maternal genome but
also the abnormal development of such tissue. Within tri-
ploid and normal placentas, digynic and diandric triploid
placentas are clearly separated by their methylation pro-
files, but, interestingly, they are not separated from the
chromosomally normal placentas (Figure 1). This suggests
that methylation profiles of triploid placentas closely
resemble those of chromosomally normal placentas, but
that digynic and diandric triploid placentas have distin-
guishing DNA methylation differences.
Although clustering can be biased by gender differ-
ences resulting from inactivation of an X chromosome
in females (that is, higher methylation of the X chromo-
some CpG islands in female than in male samples)
[22,24], there is no preferential clustering of samples by
gender within the triploid and normal placenta cluster
(Figure S1A in Additional file 1). There is a small differ-
ence in gestational age (about three weeks apart on
average) between diandric and digynic placentas (P <
0.01) (Table S1 in Additional file 2), but this also cannot
explain the distinct clustering patterns, since the gesta-
tional ages of the two groups are largely overlapping
(Table S1 in Additional file 2).
We further compared the average DNA methylation of
probes between the five sample groups (digynic triploid
placentas, diandric triploid placentas, normal placentas,
CHMs and blood) (Figure S1B in Additional file 1). As
expected, the correlation of average probe methylation
values between different sample groups is consistent
with that observed in the cluster analysis. In general,
blood has the most distinct DNA methylation profile
























































Figure 1 Unsupervised clustering of triploid and normal placentas with CHMs and blood samples demonstrates that each tissue type
has a distinct methylation profile. Sample names are shown with labelling of corresponding tissue types. Samples were clustered by
hierarchical clustering of b values based on 1-r (Illumina GenomeStudio software), where r represents the correlation coefficient between
samples. Digynic triploids are indicated by red boxes, diandric triploids by blue boxes and normal placentas by green boxes.
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with a greater number of highly methylated probes (Fig-
ure S1B in Additional file 1). Triploid and normal pla-
centas are highly correlated with regard to their
methylation profiles (r = 0.99), while CHMs are more
similar to diandric and normal placentas (r = 0.98) than
to digynic placentas (r = 0.96).
Comparison of DNA methylation profiles between
placentas from diandric and digynic triploidies
After comparing methylation between diandric and digy-
nic placentas by performing Student’s t-test for all
probes, nearly 2,500 probes were identified with a P
value < 0.01, which is nearly ten times more than
expected by chance (Figure S1C in Additional file 1). To
adjust for multiple testing and identify candidates with a
very high likelihood of representing true differences, we
used a stringent cutoff of <0.1% false discovery rate
(FDR) by using the Significance Analysis of Microarrays
(SAM) program with 1,000 permutation comparisons
for each sample [25]. To further focus on the most
meaningful differences, we also considered only probes
with more than 15% absolute magnitude difference
between the mean methylation of diandric and digynic
triploidies. While we expected a theoretical difference of
33.3% for imprinted sites, we used a lower cutoff
because we have observed that the actual methylation
difference may vary for some known imprinted genes
[19] and that there may be biases in the Illumina array
that result in a nonlinear relationship between the esti-
mated methylation b value and actual methylation. In
total, 122 probes were identified with <0.1% FDR and
average absolute methylation difference >15% (average
absolute Δ b >0.15 from the Illumina array). Probes
with higher average methylation in diandric than digynic
triploidies were designated putative paternal differen-
tially methylated loci (DML), and probes with higher
average methylation in digynic than diandric triploidies
were designated putative maternal DML. Plotting DNA
methylation of putative DML in all samples from dia-
ndric against digynic triploidies showed a clear separa-
tion of methylation values of paternal and maternal
DML (Figure S1D in Additional file 1), suggesting that
most of the identified differentially methylated probes
are consistently methylated within each sample group
without much overlap as expected on the basis of our
application of stringent statistical criteria.
As some methylation differences between diandric and
digynic triploids could theoretically arise as a result of
secondary effects, such as altered cell composition, the
validity of the identified putative imprinted DML was
further evaluated by verifying that the methylation levels
of diandric CHMs and chromosomally normal placentas
fit the expected pattern (Figure 2). The average methyla-
tion in CHMs was closer in value to that of diandric
triploidies (Figures 2A and 2C), while that for normal
placentas fell between that for diandric and digynic tri-
ploidies for the majority of putative DML (Figures 2B
and 2D) as would be expected for imprinted DMRs. The
putative maternal DML were more strongly correlated
with normal placentas than paternal DML, while puta-
tive paternal DML tended to have higher correlation
with CHMs than maternal DML (Figure 2 and Figure
S1E in Additional file 1). CHMs showed particularly low
correlation for maternal DML compared with other pla-
cental groups, which was largely due to the low average
methylation of putative maternal DML in CHMs as well
as more variability in values for CHMs (Figure 2D).
Fourteen probes failed to follow the expected relative
methylation patterns between the between groups (nor-
mal placentas with an average methylation level between
that for diandric and digynic placentas and CMHs with
an average methylation level closer to that in diandric
placenta), and these loci were eliminated as candidates
for further analysis. This yielded a final list of 108 iden-
tified putative DML that are associated with 63 different
DMRs from 62 genes (one gene with both paternal and
maternal DML) (Table S2 in Additional file 2). Of the
63 DMRs, 37 are maternally methylated and 26 are
paternally methylated (Figure 3). These imprinted DMRs
are distributed across the whole genome, with chromo-
some 7 containing the highest number (nine DMRs),
while chromosomes 13, 21 and Y are the only chromo-
somes for which no DMRs were identified (Figure 3).
As copy number variation (CNV) can be a potential
bias for methylation [26], we referred to the UCSC Gen-
ome Brower database (hg18) (http://www.genome.ucsc.
edu) and found that the locations of 37 of the 108
probes overlap with known CNVs (Table S2 in Addi-
tional file 2). However, any effect of the CNVs on
methylation of the candidate sites identified by our cri-
teria was minimal, since the methylation of maternal
and paternal DML were clearly separated from each
other without much overlap (Figure S1D in Additional
file 1). Similarly, differences between the two groups are
unlikely to be caused by differences in genetic sequence
polymorphisms that influence methylation, as this would
require all ten diandric placentas, by chance, to be of a
different genotype from all ten dygynic placentas.
Validation of DNA methylation patterns of identified
putative imprinted DMRs
The microarray included 374 CpG sites in the promoter
regions of 59 genes that have previously been reported
to be imprinted in humans based on the literature [12]
and information in Internet databases (http://igc.otago.
ac.nz/ and http://www.geneimprint.com/) (Table S3 in
Additional file 2). For nine of these genes (PRIM2A,
IGF2R, TFP12, COPG2, KLF14, ABCA1, INPP5F,
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IGF2AS and BLCAP), the included CpG sites were
unmethylated (or very lowly methylated) in the normal
human placentas, as well as in the triploid placentas
(Table S3 in Additional file 2). The majority (39 of 50)
of the remaining genes showed differences between dia-
ndric and digynic triploids at one or more of the asso-
ciated CpG sites (t-test, P < 0.05), though typically not
all CpG sites were differentially methylated.
Among the 62 genes identified with parent-of-origin-
dependent DMRs (using the stricter criteria of <0.1%
FDR and absolute average mean difference >15%), 18
are known imprinted genes associated with 15 distinct
DMRs. Two of the identified DMRs, associated with the
imprinted genes CDKN1C and RASGRF1, have been
reported only in mice and not in humans [3,12] (Table
1). While our strict selection criteria yielded only 18 of
the 39 known imprinted genes that were statistically sig-
nificantly different between diandric and digynic triploi-
dies using an uncorrected P < 0.05 (Table S3 in
Additional file 2), the missed cases were largely due to
the mean difference being less than the 15% average
methylation difference cutoff. Eleven of the fifteen
imprinted DMRs are known to be ICRs with a parental
origin of methylation concordant with what we observed
based on the comparison of triploidies (Table 1).
To confirm the methylation differences using an inde-
pendent approach, we performed bisulphite pyrosequen-
cing for a subset of the novel imprinted DMRs. For this
purpose, ten DMRs were selected on the basis of their
low FDR (FAM50B, MCCC1, DNAJC6, SORD and
RHOBTB3) or their biological significance to the pla-
centa (APC, DNMT1, IGFBP1, LEP and RASGRF1). A
high correlation between the values obtained by micro-
array and pyrosequencing was observed (r = 0.85 to
0.98; P < 0.0001) (Figures S2A to S2J in Additional file
1). Specifically, the DNA methylation patterns observed
by pyrosequencing were concordant with those found
by microarray for both (1) CpG sites analyzed by micro-
array and their the proximal CpG sites within the pyro-
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Figure 2 Scatterplots of average methylation of paternal and maternal DML. (A) and (C) Average methylation values in normal placentas
(x-axis) plotted against digynic triploids (Avg G), diandric triploids (Avg A) and CHMs (Avg C) show high correlation. (B) and (D) Average
methylation values in CHMs (x-axis) plotted against digynic triploids (Avg G), diandric triploids (Avg A) and normal placentas (Avg N).
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1) and (2) the average methylation levels of all CpG sites
covered by pyrosequencing (Figures S4A to S4J in Addi-
tional file 1). DNA methylation levels of the selected
loci were also assessed in sperm DNA and all were
unmethylated (data not shown), suggesting they may be
either secondary DMRs or maternal imprinted DMRs.
We further evaluated DNA methylation for two genes,
FAM50B and MCCC1, which contain SNPs with high
average heterozygosity (about 0.4) in the proximal pro-
moter regions that can be used to distinguish alleles
(Figures 4A and 4F). Most of the other identified genes
do not contain common SNPs in the nearby analyzed
regions that could be used for this purpose. Bisulphite
cloning and sequencing confirmed monoallelic methyla-
tion patterns for both DMRs (Figures 4C and 4H) and
maternal origin of allelic methylation that was concor-
dant with that predicted by the triploidy comparison
(Figures 4B and 4G). Furthermore, allelic expression
analysis showed preferential expression of the unmethy-
lated paternal allele at the proximal promoter regions
(Figures 4E and 4I), which is consistent with an inverse
correlation between methylation and expression. As
allelic methylation can occur in a SNP-dependent man-
ner [27], we developed a methylation-specific pyrose-
quencing assay for FAM50B to evaluate allelic
methylation in additional samples. This same approach
could not be applied to MCCC1, because its interro-
gated SNP is located at a CpG site. The results of the
FAM50B assay were concordant with cloning and
sequencing results for the same placental sample (Fig-
ures 4C and 4D). As methylation was found in associa-
tion with either allele (A or G at rs2239713) among 12
heterozygous normal term placental samples and ten
heterozygous maternal blood samples (Table S4 in Addi-
tional file 2), the allelic methylation is not linked to the
SNP genotypes, at least for this DMR.
Since diandric triploid placentas tend to be associated
with trophoblast hyperplasia [17], we considered the
possibility that some of the identified imprinted DMRs
reflect differences in methylation between the tropho-
blast and mesenchyme, the two components of the
chorionic villi [28]. To address this hypothesis, we used
a nonimprinted, trophoblast-specific unmethylated
























































Figure 3 Location of the 63 identified DMRs in the genome. Relative location of the identified 37 maternal DMRs and 26 paternal DMRs are
shown in the human genome according to the genomic sequence released in 2006 in the UCSC Genome Browser database (hg18). Paternal
DMRs are highlighted in blue and maternal DMRs are highlighted in red. Known imprinted genes are boldfaced and underlined. Chromosome 7
contains the highest number of DMRs (nine DMRs), while there are no DMRs identified on chromosomes 13, 21 and Y.
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compare the methylation levels between diandric and
digynic triploid placentas. However, we did not find a
difference in methylation levels between them at this
site (Figure S5B in Additional file 1). Likewise, we did
not find any differences in allelic methylation between
trophoblast and mesenchyme for the novel identified
imprinted gene MCCC1 (Figures S5C and S5D in Addi-
tional file 1). However, DNAJC6 and RASGRF1 showed
differential methylation between trophoblast and
mesenchyme (Figure S6 in Additional file 1), which may
represent cell-type-specific imprinting.
Confirmation of parent-of-origin allelic expression for the
identified putative imprinted genes
While the existence of an imprinted DMR is thought to
be predictive of imprinting at the gene expression level,
proving this is complicated by the fact that imprinted
DMRs may exist in association with imprinted genes
even in tissues where the gene is not expressed or is
expressed in a biallelic manner. Furthermore, to be
informative for demonstrating monoallelic expression,
the placental sample must be heterozygous for an
expressed SNP. To be informative for parental origin of
the expressed allele, the mother must additionally be
homozygous for the same SNP.
As many previously reported imprinted genes are
expressed in an imprinted manner in placenta, and
since we needed to screen many placenta-mother pairs
to find informative cases, we proceeded to investigate
the parental origin of allelic expression for the novel
putative imprinted genes using a high-throughput geno-
typing approach, specifically the iPLEX Gold assay on
the MassARRAY platform (Sequenom, Inc., San Diego,
CA, USA). We selected 38 of 45 genes associated with
novel imprinted DMRs (the 45 putative imprinted genes
including RASGRF1, for which imprinted expression has
not been reported in humans) on the basis of the avail-
ability of an exonic SNP with high average heterozygos-
ity (>0.1) and the presence of expression in the placenta
according to the GNF atlas database (http://biogps.gnf.
org/). In addition, two exonic SNPs from IGF2 were
included as positive controls, since IGF2 is well known
to exhibit imprinted expression in human placentas.
Thus, a total of 40 SNPs were genotyped in 27 mater-
nal-foetal pairs, including DNA from maternal blood
and the corresponding foetal normal term placenta, as
well as cDNA from the same placenta.
Of these 40 SNPs, 7 did not pass the quality control
criteria (<70% calls or presence of severe allelic bias)
and 3 had no informative (heterozygous) genotypes in
foetal DNA, leaving a total of 30 SNPs for analysis
(Table S5 in Additional file 2). The two SNPs from
IGF2 showed the expected paternal allelic expression in
all informative cases (Table S5 in Additional file 2). Of
the 28 novel putative imprinted genes, 11 showed
monoallelic expression in at least a portion of informa-
tive samples (Table 2). Among these 11 genes, 8 had
cases informative (homozygous) in maternal blood for
parental origin assessment. Since most CpG sites in the
microarray are located at the proximal promoter regions
of the genes, we assumed that the DNA methylation
would most likely correlate with silencing for all these
genes. Six genes (FAM50B, DNMT1, RHOBTB3,
ARMC3, AIFM2 and LEP) showed parent-of-origin-
dependent expression that matched that predicted by
the parental origin of the DMRs, while two others
(MOV10L1 and ST8SIA1) showed parental expression
opposite that predicted in one or more informative
cases (Table 2). For FAM50B and RHOBTB3, monoalle-
lic expression for both reciprocal forms of the SNP was
also observed. Some genes with imprinted DMRs may
not show allele-specific expression biases because of the
presence of tissue-specific or gestational age-specific
imprinting that is further regulated by DNA methylation
at other nearby sites.
A number of genes did not consistently show monoal-
lelic expression using the iPLEX Gold assay. For exam-
ple, for LEP, only 1 of 15 samples was scored as
monoallelic using this approach. To evaluate the sensi-
tivity of the iPLEX Gold genotyping assay for detecting
allelic biases in expression, we developed an RNA-speci-
fic genotyping pyrosequencing assay for LEP. Although







1p31 DIRAS3 P - M M
4q22.1 NAP1L5 P M M M
6q24 PLAGL1 P M M M
7p12 GRB10 M/Pb M M M
7q21.3 PEG10/
SGCE
P M M M
7q32.2 MEST P M M M
11p15 CDKN1C M - Pc P
11p15 H19 M P P P
11p15 KCNQ1d M M M M
14q32 MEG3 M P P P
15q11-
q12
SNURF P M M M
15q24 RASGRF1 P - Pc M
16p13 ZNF597 M - - P
19q13.43 PEG3/ZIM2 P M M M
20q13 GNAS
(NESP)
M - P P
20q13 GNAS (XL) P M M M
20q13 L3MBTL P - M M
aDMR, differentially methylated region; ICR, imprinting control region; btissue-
specific parental origins of allelic expression; cparental origins based on
mouse studies; dregion known as KvDMR1.
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the two methods were correlated (r = 0.64; P < 0.02), we
found that pyrosequencing was more likely to detect
preferential allelic expression, with 5 of 12 informative
cases exhibiting a <0.3 allelic ratio by pyrosequencing
(Table S6 in Additional file 2). Furthermore, in case
PM155 for MCCC1, we found preferential paternal
allelic expression by pyrosequencing (Figure 4I), but not
by iPLEX Gold genotyping (Table 2). Thus, the iPLEX
Gold assay may not be sufficiently sensitive to detect
more subtle allelic expression bias, that is, in circum-
stances where there is a mix of cells with biallelic and
monoallelic expression.




































































Figure 4 Identification of imprinted DMRs at the proximal promoter regions of FAM50B and MCCC1. (A) and (F) Schematics showing the
positions of methylation assays (Biseq: bisulphite cloning and sequencing assay; cg code: probe number of Illumina assay; and Pyro: bisulphite
pyrosequencing assay) and SNP locations relative to the genes. Arrow directions represent the transcriptional directions for the genes. Genomic
coordinates were retrieved from the UCSC Genome Brower database (hg18). (B) and (G) Box plots showing the methylation levels of samples
from each placental group for the DMRs analyzed by bisulphite pyrosequencing. Both DMRs in FAM50B and MCCC1 have higher methylation in
digynic than diandric triploid placentas, while they have intermediate methylation in normal placentas and particularly low methylation in CHMs.
(C) and (H) Bisulphite cloning and sequencing showing parental origins of methylated and unmethylated alleles (M: maternal alleles; P: paternal
alleles). Parental origin was determined by genotyping heterozygous informative SNPs for each sample. The DMRs in both FAM50B and MCCC1
are maternally methylated. Each black circle represents a methylated CpG dinucleotide, and each white circle represents an unmethylated CpG
dinucleotide. (D) Quantitative genotyping of methylated alleles by pyrosequencing. SNP rs2239713 is homozygous (GG) in maternal DNA and
heterozygous (AG) in foetal (placental) DNA (dispensation order: AAG). Genotyping of the placental sample using a methylation-specific
pyrosequencing primer shows a homozygous (GG) pattern, indicating that the DMR associated with the maternally inherited ‘G’ allele is
methylated while the one associated with the paternal ‘A’ allele is not. (E) and (I) Quantitative genotyping of expressed alleles by
pyrosequencing. Both SNPs (E) rs6597007 (dispensation order: GGC) and (I) rs937652 (dispensation order for DNA genotyping: CG; dispensation
order for RNA genotyping: CCG) are homozygous in maternal DNA and heterozygous in foetal DNA. Genotyping of cDNA shows a bias towards
preferential expression of the paternal alleles. *The pyrosequencing primers used for cDNA genotyping (intron-spanning) in MCCC1 were
different from those used for DNA genotyping (Table S10 in Additional file 2), so the peak ratio shown in genotyping the pyrogram of cDNA
does not correspond to that for DNA.
Yuen et al. Epigenetics & Chromatin 2011, 4:10
http://www.epigeneticsandchromatin.com/content/4/1/10
Page 8 of 16
Tissue-specific and gestational age-specific methylation of
imprinted DMRs
To study tissue-specific effects and the effect of gesta-
tional age on methylation of the putative imprinted
DMRs, we further compared methylation at these sites
among three types of foetal somatic tissues (eight brain
samples, twelve kidney samples and eleven muscle sam-
ples) and two sets of placentas with different gestational
ages (ten midgestation and ten term placentas) that had
been run in the same Infinium HumanMethylation27
BeadChip array.
For tissue-specific methylation analysis, we compared
the DNA methylation levels of the 108 DML (probes)
associated with the 63 imprinted DMRs in five tissues
(brain, kidney, muscle, midgestation placenta and blood).
Multiclass comparison from SAM was performed with
1,000 permutations. Using a <0.1% FDR cutoff, 53 probes
of 46 imprinted DMRs showed differential DNA methyla-
tion between tissues (Table 3 and Table S7 in Additional
file 2). Placenta-specific methylation was observed for 31
of these probes (26 imprinted DMRs), with the average
methylation being more than 15% higher in placenta than
in any other tissues (Table 3 and Table S7 in Additional
file 2). A change in methylation of placenta by gestational
age was found for 12 probes from ten DMRs using the
same statistical criterion (<0.1% FDR) (Table 3 and Table
S8 in Additional file 2). Thus, imprinted DMRs can show
both tissue-specific and gestational age-specific DNA
methylation. Nonetheless, 14 of the imprinted DMRs
showed constant methylation between different tissues
and gestational ages (Table 3 and Table S9 in Additional
file 2), 11 of which are in ICRs from known imprinted
genes. Three identified imprinted DMRs associated with
FAM50B, FGF12 and IRF7 also remained constant across
samples and are thus potential ICRs or primary DMRs.
The complexity of DNA methylation associated with
imprinted genes can be illustrated by the data for three
known imprinted genes, GNAS, CDKN1C and MEST,
for which multiple probes were present on the Infinium
HumanMethylation27 BeadChip array. For GNAS, the
array contains probes for 30 CpG sites mapping across
three promoter regions of three alternative transcripts
(NESP55, GNASXL and exon 1A of GNAS) (Figure 5A).
As previously reported, the paternal DMR is located at
the promoter of NESP55 transcript (Figure 5B), while
the maternal DMR is located at the promoter of
GNASXL [29]. While most of the CpG sites have more
or less equal average methylation across the locus,
cg15160445 to cg1683351 and cg01565918 show clear
tissue-specific methylation across different tissues (Fig-
ures 5B to 5D). For CDKN1C, there are eight probes
present in the array (Figure 5E). A previously unidenti-
fied paternal DMR was identified at the promoter region
of this gene through our comparison of triploids (Figure
5F). Interestingly, not only is the imprinted DMR itself
tissue-specific (that is, it is a secondary DMR) (Table 3)
but there is also a probe (cg20919799) that shows differ-
ential methylation across different gestational ages
(Figure 5G) and tissues (Figure 5H). Likewise, for
MEST, for which ten probes span two regions of the
gene (Figure S7A in Additional file 1), an imprinted
DMR can be found in one region (Figures S7B and S7C
in Additional file 1), while tissue-specific and gestational
age-specific methylation is observed in another region of
the MEST promoter (Figures S7C to S7G in Additional
file 1).
Discussion
Many efforts have been made to identify imprinted genes
in the human genome because of their importance in
Table 2 Eleven genes associated with candidate imprinted DMRs with confirmed monoallelic expressiona
Gene DMR SNP Monoallelic expression,
observed/total (%)
Monoallelic expression observed for
reciprocal SNPb
Matched expected parental origin,
observed/total (%)c
FAM50B M rs6597007 9/9 (100) Y 5/5 (100)
DNMT1 M rs16999593 1/1 (100) - 1/1 (100)
MOV10L1 P rs9617066 8/9 (89) N 1/3 (33)
RHOBTB3 M rs34896 3/4 (75) Y 2/2 (100)
SNCB M rs2075667 3/4 (75) N NI
ARMC3 M rs12259839 2/3 (67) N 2/2 (100)
ST8SIA1 M rs4762737 2/3 (67) Y 0/1 (0)
ARHGAP4 P rs2070097 1/2 (50) - NI
AIFM2 M rs7908957 2/8 (25) N 1/1 (100)
MCCC1 M rs937652 2/8 (25) Y NI
LEP P rs2167270 1/15 (7) - 1/1 (100)
aDMR, differentially methylated region; SNP, single-nucleotide polymorphism; NI, not informative. bWhere both alleles of SNP were observed to be expressed
among cases with monoallelic expression; this is impossible to determine if only one case showed monoallelic expression. cNumber of cases matching the
expected parental origin of those cases informative with regard to determining parent of origin.
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Table 3 DNA methylation of identified DMRs in different tissues and gestational agesa
Index Gene Chromosome Tissue-specificb Change in gestationc Stable non-tissue-specificd Known imprinted genese
1 DNAJC6 1 Yf Y N N
2 LASS2 1 Yf Y N N
3 PEX5 12 Yf Y N N
4 RASGRF1 15 Yf N N N
5 AKAP10 17 Yf N N N
6 AIFM2 10 Yf N N N
7 APC 5 Yf N N N
8 ARHGAP4 X Yf N N N
9 ARMC3 10 Yf N N N
10 C3orf62 3 Yf N N N
11 CD83 6 Yf N N N
12 CMTM3 16 Yf N N N
13 DNMT1 19 Yf N N N
14 G0S2 1 Yf N N N
15 GATA4 8 Yf N N N
16 LEP 7 Yf N N N
17 MCCC1 3 Yf N N N
18 NUDT12 5 Yf N N N
19 PCK2 14 Yf N N N
20 RHOBTB3 5 Yf N N N
21 SLC46A2 9 Yf N N N
22 SNCB 5 Yf N N N
23 SORD 15 Yf N N N
24 ST8SIA1 12 Yf N N N
25 TBX6 16 Yf N N N
26 TMEM17 2 Yf N N N
27 ZNF232 17 Yf N N N
28 ZNF396 18 Yf N N N
29 AK094715 6 Y Y N N
30 DIRAS3 1 Y Y N Y
31 CMTM8 3 Y Y N N
32 SEMA3B 3 Y Y N N
33 CDKN1C 11 Y N N Y
34 H19 11 Y N N Y
35 KCNQ1 11 Y N N Y
36 MEG3 14 Y N N Y
37 PEG10 7 Y N N Y
38 C10orf125 10 Y N N N
39 CCR10 17 Y N N N
40 CYP2W1 7 Y N N N
41 FIGNL1 7 Y N N N
42 IGFBP1 7 Y N N N
43 MOV10L1 22 Y N N N
44 P2RY6 11 Y N N N
45 PARP12 7 Y N N N
46 SAMD10 20 Y N N N
47 L3MBTL 20 N Y N Y
48 ACPL2 3 N Y N N
49 REEP6 19 N Y N N
50 GNAS(M) 20 N N Y Y
51 GNAS(P) 20 N N Y Y
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foetal growth and development and their potential for
dysregulation [11,12]. Most known imprinted genes to
date were first identified in mice, but many imprinted
genes are not conserved across species [5]. In the present
study, we utilized diandric and digynic triploid placentas
to map imprinted DMRs, sites that are typically asso-
ciated with imprinted genes, in the human genome. We
identified 11 of the 18 previously reported human ICRs
covered by the Illumina Infinium HumanMethylation27
BeadChip panel, with additional ones which showed dif-
ferences that were insufficient to reach our stringent sta-
tistical criteria. Furthermore, we confirmed the parent-of-
origin dependence of methylation and expression in a
subset of our candidate novel imprinted genes on the
basis of independent experiments.
This approach improves upon previous strategies for
mapping imprinted DMRs, such as comparing partheno-
genotes (ovarian teratomas) and androgenotes (CHMs)
[13,14], which is limited by the grossly abnormal nature
of these samples, or comparing maternal and paternal
uniparental disomies (UPDs) [30,31], which is restricted
by the rarity of UPDs for many chromosomes and the
limited tissues available for analysis. Although triploid
placentas do exhibit some abnormal pathology, their cel-
lular composition is comparable and methylation pro-
files of both types of triploidy were closely correlated
with chromosomally normal placentas (r = 0.99). In
comparison, a previous study showed that mature ovar-
ian teratomas have a methylation profile more similar to
that of blood (r = 0.94) than to either CHMs (r = 0.84)
or normal placentas (r = 0.88) [14]. Genome-wide tran-
scriptome analysis has also been used to identify
imprinted genes [11,32], but it is gene expression- and
SNP-dependent; thus, imprinted genes with tissue-speci-
fic expression or lacking a heterozygous exonic SNP
would be missed.
As demonstrated, tissue-specific methylation of
imprinted DMRs or their flanking regions can readily be
assessed by comparing methylation profiles of a variety
of tissues, allowing a comprehensive analysis of tissue-
specific methylation regulation at complex loci, such as
GNAS [29]. The regional dependent methylation pat-
terns in the promoters of imprinted genes show the
importance of locating the specific CpG sites defining
the imprinted DMRs when studying the dynamics of
promoter DNA methylation at such genes. While in the
present study we identified only loci that demonstrated
parent-of-origin-dependent differential DNA methyla-
tion in placenta, most known imprinted genes show par-
ent-of-origin-specific expression in this organ [2].
Furthermore, as diandric and digynic triploids can both
exist as foetuses, additional comparisons could be used
to identify any potential genes that exhibit imprinting
specifically in other tissues. This study is limited by the
low coverage of CpG sites in the array (about two CpG
sites on average for each proximal promoter region of
genes), which reduces its power to identify imprinted
DMRs as these may be limited to specific regions within
the promoter. This analysis could thus be extended
further by using microarray or whole-genome sequen-
cing with greater coverage of the genome.
Overall, the number of imprinted DMRs identified in
the present study was less than that predicted by bioin-
formatics approaches [33]. However, the stringent selec-
tion criteria (<0.1% FDR and absolute average
methylation difference >15%) that we used to pick the
top candidate sites caused an underestimation of the
number of imprinted loci. Many more candidate
imprinted DMRs can be identified with this data set
using lower thresholds. In fact, many known imprinted
genes that we failed to identify on the basis of these cri-
teria did show nominally significant (P < 0.05 without
Table 3 DNA methylation of identified DMRs in different tissues and gestational agesa (Continued)
52 GRB10 7 N N Y Y
53 MEST 7 N N Y Y
54 NAP1L5 4 N N Y Y
55 PEG3 19 N N Y Y
56 PLAGL1 6 N N Y Y
57 SGCE 7 N N Y Y
58 SNURF 15 N N Y Y
59 ZIM2 19 N N Y Y
60 ZNF597 16 N N Y Y
61 FAM50B 6 N N Y N
62 FGF12 3 N N Y N
63 IRF7 11 N N Y N
aDMR, differentially methylated region; bmulticlass comparison of methylation level in brain, kidney, muscle, midgestation placenta and blood with FDR <0.1%;
cMulticlass comparison of methylation level in early-gestation, midgestation and term placenta, FDR <0.1%; dDMRs with no statistically significant changes in
methylation level in different tissues and gestational ages; eBased on the public databases (http://igc.otago.ac.nz/ and http://www.geneimprint.com/); fplacenta-
specific methylation.
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Figure 5 Illustration of tissue-specific and gestational age-specific methylation at the proximal promoter regions of GNAS and
CDKN1C. (A) and (E) Schematics showing the positions of the Illumina Infinium probes relative to the genes and transcripts. Arrow directions
represent the transcriptional directions for the genes or transcripts. Genomic coordinates were retrieved from the UCSC Genome Brower
database (hg18). (B) through (D) Average methylation levels of the Illumina Infinium probes in different placental groups (top) and in different
tissues (bottom). Probe numbers are shown on the x-axes in the bottom panels divided into (B) GNAS region 1, (C) GNAS region 2 and (D) GNAS
region 3 according to their proximity to the known transcripts. Tissue-specific methylation can be found from cg15160445 to cg16833551 in
GNAS region 2 and at cg01565918 in GNAS region 3. (F) through (H) Average methylation levels of the Illumina Infinium probes of CDKN1C in
(F) different placental groups, (G) different gestational ages of placenta and (H) different tissues. Probe numbers are shown on the x-axes. Both
tissue-specific and gestational age-specific methylation can be found at cg20919799. PLN(E): early gestation placenta; PLN(M): midgestation
placenta; PLN(T): term placenta; MUS: muscle; BRN: brain; KID: kidney; WB: whole blood.
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correction for multiple comparisons) DNA methylation
differences between diandric and digynic triploids (Table
S3 in Additional file 2). For instance, a recently con-
firmed imprinted gene, RB1 [34], was significantly differ-
entially methylated between diandric and digynic
triploidies (<0.1% FDR), with a methylation pattern con-
sistent with that of a maternal DMR (data not shown).
However, it was excluded because its absolute average
methylation difference between diandries and digynies
was only 14%. While we expect imprinted DMRs to
show a difference of 33% between the triploid groups,
smaller differences may be observed owing to a lack of
complete methylation at all CpG sites on the inactive
allele or to the presence of a mix of cell types, only
some of which are imprinted. Similarly, methylation on
the inactive X chromosome in females is incomplete
(much less than 50%) in the placenta for gene promoter
regions that are typically methylated at 50% in somatic
tissues, despite still showing a significant increase in
methylation relative to male placenta [22].
Only some of the novel putative imprinted DMRs
could be confirmed to show monoallelic expression, and
others did not show strict parent-of-origin expression in
all placentas (Table S5 in Additional file 2). There are
several possible explanations. First, there may be cell- or
tissue-specific imprinting confounding the ability to
detect a difference in whole villous samples from term
placentas. Many known imprinted genes show imprinted
expression only in specific placental cell types, for exam-
ple, Mash2 in mice, which is differentially expressed
only in diploid trophoblast cells of the postimplantation
embryo [35], and STOX1 in humans, which is mater-
nally expressed in extravillous trophoblast cells [36].
Given the highly heterogeneous cell types present in the
placenta [28], nonimprinted expression in some cells
may mask allelic expression in others. The possibility
that cell heterogeneity exists for the DMRs identified in
the present study is supported by the observations that
(1) average methylation of some candidate DMRs was
not the expected 50% in normal placentas (Figure S3
in Additional file 1) and (2) DNAJC6 and RASGRF1
showed differential methylation between trophoblast
and mesenchyme (Figure S6 in Additional file 1). Sec-
ond, as we have shown, the iPLEX Gold assay may not
be sensitive enough to pick up subtle allelic expression
biases (Table S6 in Additional file 2).
Third, there may be alternative transcripts regulated
by alternative promoters that are not imprinted, so the
observed expressed allelic ratio at particular SNPs may
be complicated by the synergic effect of multiple tran-
scripts. Such complex regulation is observed for known
imprinted genes such as GNAS, CDKN1C and MEST
(Figure 5 and Figure S5 in Additional file 1). However,
allelic expression from either parent in some genes,
such as MOV10L1 and ST8SIA1, suggests that some of
the identified DMRs may be random monoallelically
expressed genes instead of imprinted genes (with DNA
methylation differences between diandries and digynies
occurring by chance).
The validation of all the putative imprinted DMRs we
identified is limited by the number of samples and com-
mon SNPs within regions and by the availability of
intact mRNA from the pathological specimens. A proper
validation experiment to demonstrate that the DMRs we
have identified are associated with imprinted methyla-
tion and gene expression requires being able to trace
the parental origin of the methylated and expressed
alleles in multiple members of the same family, which
can be done in mice but is impractical and ethically
impossible to do across multiple tissues in humans [37].
The best alternative is to trace the origin of the methy-
lated allele and the expressed allele in multiple indivi-
duals. This requires a SNP adjacent to the methylation
site that is heterozygous in the test sample but homozy-
gous in one parent. Using this strategy, we demon-
strated for FAM50B that (1) a maternal origin of the
methylated allele in placenta and blood from multiple
individuals and on reciprocal genetic backgrounds and
(2) the paternal allele is expressed with either SNP allele
in the placenta, thus ruling out the possibility of a
genetic effect. Confirming that an imprint represents a
primary imprinted DMR requires detailed investigations
of postfertilization imprinting dynamics, which is diffi-
cult to perform in humans. Nonetheless, we showed
that the methylation level of FAM50B is similar in mul-
tiple tissues and is unmethylated in sperm, suggesting
that it is likely to be a primary maternal DMR. During
the revision of this manuscript, the maternal imprint of
FAM50B was also confirmed by other groups using
similar validation methods [38,39]. The goal of the pre-
sent study was to demonstrate the ability of our
approach to identify imprinted DMRs, not to map and
confirm every imprinted DMR on the array. Thus, the
putative imprinted DMRs listed in the present study
should be considered with caution, and further valida-
tion is required.
Two genes identified as potentially being imprinted in
the present study, APC and DNMT1, were excluded as
being imprinted in previous studies [40,41], while APC
was reported as being imprinted in another study [42].
Of interest, DNMT1 is a DNA methyltransferase that is
important for the maintenance and establishment of
DMRs in imprinted genes [43], while APC is a negative
regulator of the Wnt signalling pathway, which has been
implicated in the survival, differentiation and invasion of
human trophoblasts [40]. Although Dnmt1 was found to
be dispensable for growth of the extraembryonic
lineages in mice [44], it is not methylated at the
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orthologous region in mice [41]. Both the APC and
DNMT1 DMRs were reported to be specifically methy-
lated in primate placentas [45], suggesting that the
potential imprinting marks of these genes emerged fairly
recently in evolution. This is also consistent with the
hypothesis that maternal imprints are under selective
pressure during early development for methylation-
dependent control [46]. This could occur by selecting
genes with developmental advantage by gain of imprint-
ing from epipolymorphisms [47].
Conclusions
In conclusion, we have demonstrated that comparison of
diandric and digynic triploids is an effective method for
mapping imprinted DMRs in the human genome. This
approach can be extended to different tissues, gestational
ages or species, thereby generating a comprehensive view
of imprinting regulation and evolution. The ability to
map novel imprinted DMRs in the human genome
should improve our understanding of the causes of pla-
cental dysfunction and birth defects. With the rapid
advancement of molecular genetics technologies, a com-
plete map of imprinted DMRs may ultimately be gener-
ated by the use of whole-genome sequencing. However,
the present approach is a convenient, currently available
and cost-effective method of imprinted gene mapping.
Methods
Sample collection
This study was approved by the ethics committees of
the University of British Columbia and the Children’s &
Women’s Health Centre of British Columbia. Early
gestation placental samples (ten diandric triploids, ten
digynic triploids, six CHMs and ten normal controls)
were obtained from spontaneous abortions examined in
the Children’s & Women’s Health Centre of British
Columbia pathology laboratory. The parental origin of
triploids was determined by using microsatellite poly-
morphisms as previously described [17-19], and these
studies also allowed us to exclude maternal contamina-
tion in the placental samples. Midgestation placental
samples (n = 10) and foetal tissues (11 muscle samples,
12 kidney samples and 8 brain samples) were obtained
from anonymous, chromosomally normal, second-trime-
ster elective terminations for medical reasons. Term pla-
cental samples and the corresponding maternal blood
samples were collected from Children’s & Women’s
Health Centre of British Columbia with the women’s
written informed consent. For all placental samples,
fragments of about 1 cm3 were dissected from the foetal
side and whole villi were used for investigation. All tis-
sues were karyotyped for chromosomal abnormalities,
and genomic DNA was extracted from each tissue sam-
ple using standard techniques. Total RNA was extracted
from term placentas using an RNeasy kit (Qiagen,
Valencia, CA, USA) according to the manufacturer’s
instructions.
Illumina DNA methylation array
Genomic DNA was bisulphite-converted using the EZ
DNA Methylation Kit (Zymo Research, Orange, CA,
USA) according to the manufacturer’s instructions. Bisul-
phite treatment converted unmethylated cytosines to ura-
cils while leaving methylated cytosines unchanged. After
DNA purification, bisulphite-converted DNA samples
were randomly arrayed and subjected to the Infinium
HumanMethylation27 BeadChip panel array-based assay.
The array assays methylation levels at 27,578 CpG sites
in the human genome. The methylation level for each
CpG site was measured by the intensity of fluorescent
signals corresponding to the methylated allele (Cy5) and
the unmethylated allele (Cy3). Cy5 and Cy3 fluorescence
intensities were corrected independently for background
signal and normalized using GenomeStudio software
(Illumina, Inc.). Continuous b values that range from 0
(unmethylated) to 1 (methylated) were used to identify
the percentage of methylation, from 0% to 100%, for each
CpG site. The b value was calculated based on the ratio
of methylated/(methylated + unmethylated) signal out-
puts. The detection P value of each probe was generated
by comparison with a series of negative controls
embedded in the assay. Probes with detection P values
>0.05 in any of the samples were eliminated from the
study. The correlation coefficient for technical replicates
was >0.98. The microarray data from this study have
been submitted to the NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo) under accession num-
ber GSE25966.
DNA methylation analyses for targeted loci
Methylation-unbiased PCR and sequencing primers were
designed based on the probe sequences provided by Illu-
mina (Table S10 in Additional file 2). All primers were
designed in regions free of known SNPs. Pyrosequencing
was performed using a PyroMark MD system (Biotage,
Uppsala, Sweden). The quantitative levels of methylation
for each CpG dinucleotide were evaluated using Pyro
Q-CpG software (Biotage). For bisulphite cloning and
sequencing, the PCR product from individual samples
was generated by using non-biotinylated primers (Table
S10 in Additional file 2) and subsequently TA-cloned
into the pGEM-T Easy Vector System (Promega, Madi-
son, WI, USA). Individual clones were picked and PCR-
amplified with SP6 and T7 promoter primers. PCR pro-
ducts were sequenced by using Sanger sequencing. The
sequencing data were analyzed using BiQ Analyzer Soft-
ware [48], and sequences with less than an 80% bisul-
phite conversion rate were eliminated from analysis.
Yuen et al. Epigenetics & Chromatin 2011, 4:10
http://www.epigeneticsandchromatin.com/content/4/1/10
Page 14 of 16
SNP genotyping
Multiplex genotyping of genomic DNA and cDNA was
performed by using the iPLEX Gold assay on the Mas-
sARRAY platform (Sequenom) at the Génome Québec
Innovation Centre (Montréal, PQ, Canada). Primers for
SNP genotyping were designed by using primer design
software from Sequenom (Table S11 in Additional file
2). The primer extended products were analyzed and
the genotypes were determined by mass spectrometric
detection using the MassARRAY Compact System
(Sequenom). Technical replicates showed a correlation
of r = 0.92. Samples or SNPs with <70% conversion
rates (calls) were eliminated. Genotyping by pyrosequen-
cing was performed on a PyroMark MD System, and the
relative levels of alleles for SNPs were evaluated by
using PSQ 96MA SNP software (Biotage). Genotyping
of exonic SNPs was carried out with cDNA prepared
using either (1) the Omniscript Reverse Transcriptase
Kit (Qiagen) followed by the iPLEX Gold assay or pyro-
sequencing or (2) the Qiagen OneStep RT-PCR Kit fol-
lowed by pyrosequencing. Primers for pyrosequencing
genotyping were designed by using primer design soft-
ware from Biotage (Table S11 in Additional file 2). PCR
without reverse transcriptase was performed on each
sample to confirm that there was no genomic DNA
contamination.
Statistical analysis
Unsupervised hierarchical clustering of samples was
done using Illumina GenomeStudio software. Differen-
tially methylated probes in the Illumina Infinium
HumanMethylation27 BeadChip array from each com-
parison were identified using the siggenes package from
R software with a cutoff of <0.1% FDR. FDRs were gen-
erated after comparison of 1,000 random permutations
between samples. The Pearson linear correlation coeffi-
cient was used to determine the similarity of DNA
methylation profiles between samples. The Database for
Annotation, Visualization and Integrated Discovery
(DAVID) program was used for gene ontology analysis
using the total number of genes presented in the array
as a background for comparison [49,50].
Additional material
Additional file 1: Figures S1 to S6.
Additional file 2: Tables S1 to S11.
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